+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopolymers for Medical Applications Market Research Report by Type (Bio-BE, Bio-PC, and Bio-PET), Source, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4829857
  • Report
  • April 2022
  • Region: Global
  • 199 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • BASF SE
  • DuPont de Nemours Inc
  • Evonik Industries
  • GELITA AG
  • INEOS Styrolution
  • Solvay
The Global Biopolymers for Medical Applications Market size was estimated at USD 1,275.87 million in 2021, USD 1,568.82 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 23.13% to reach USD 4,447.89 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biopolymers for Medical Applications to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Bio-BE, Bio-PC, Bio-PET, Bio-PUR, Bio-degradable Starch Blends, Cellulose Derivatives, PHA, and Regenerated Cellulose.
  • Based on Source, the market was studied across Natural and Synthetic.
  • Based on Application, the market was studied across Bioresorbable Scaffolds, Drug Delivery Systems., Healing Products, Surgical Implant Devices, Wound Closure, Dentistry, and Therapeutic Imaging.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biopolymers for Medical Applications market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopolymers for Medical Applications Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopolymers for Medical Applications Market, including BASF SE, Corbion N.V., DuPont de Nemours Inc, Eastman Chemical Company, Evonik Industries, Geistlich Pharma AG, GELITA AG, HyMedPoly, INEOS Styrolution, ITV Denkendorf Product Service GmbH, NatureWorks, PSS Polymer Standards Service GmbH, Solvay, and Toray Industries Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biopolymers for Medical Applications Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopolymers for Medical Applications Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopolymers for Medical Applications Market?
4. What is the competitive strategic window for opportunities in the Global Biopolymers for Medical Applications Market?
5. What are the technology trends and regulatory frameworks in the Global Biopolymers for Medical Applications Market?
6. What is the market share of the leading vendors in the Global Biopolymers for Medical Applications Market?
7. What modes and strategic moves are considered suitable for entering the Global Biopolymers for Medical Applications Market?
Frequently Asked Questions about the Global Biopolymers for Medical Applications Market

What is the estimated value of the Global Biopolymers for Medical Applications Market?

The Global Biopolymers for Medical Applications Market was estimated to be valued at $1275.9 Million in 2021.

What is the growth rate of the Global Biopolymers for Medical Applications Market?

The growth rate of the Global Biopolymers for Medical Applications Market is 23.1%, with an estimated value of $4447.9 Million by 2027.

What is the forecasted size of the Global Biopolymers for Medical Applications Market?

The Global Biopolymers for Medical Applications Market is estimated to be worth $4447.9 Million by 2027.

Who are the key companies in the Global Biopolymers for Medical Applications Market?

Key companies in the Global Biopolymers for Medical Applications Market include BASF SE, Corbion N.V., DuPont de Nemours Inc, Eastman Chemical Company, Evonik Industries, Geistlich Pharma AG, GELITA AG, HyMedPoly and ITV Denkendorf Product Service GmbH.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BASF SE
  • DuPont de Nemours Inc
  • Evonik Industries
  • GELITA AG
  • INEOS Styrolution
  • Solvay

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand of Biopolymers for manufacturing of medical devices, replacement and implants
5.1.1.2. Use of biopolymer as sensor for disease monitoring and efficient drug delivery systems
5.1.1.3. Development of sterilization technology
5.1.2. Restraints
5.1.2.1. Expensive development of bio-safe and non-toxic Biopolymers
5.1.3. Opportunities
5.1.3.1. Vertical collaboration between giants and medical industry and Plastic industry
5.1.3.2. R&D investment
5.1.3.3. Blending of with synthetic polymers with biopolymers to reduce the cost of the material.
5.1.4. Challenges
5.1.4.1. Issues with biocompatibility
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Biopolymers for Medical Applications Market, by Type
6.1. Introduction
6.2. Bio-BE
6.3. Bio-PC
6.4. Bio-PET
6.5. Bio-PUR
6.6. Bio-degradable Starch Blends
6.7. Cellulose Derivatives
6.8. PHA
6.9. Regenerated Cellulose
7. Biopolymers for Medical Applications Market, by Source
7.1. Introduction
7.2. Natural
7.3. Synthetic
8. Biopolymers for Medical Applications Market, by Application
8.1. Introduction
8.2. Bioresorbable Scaffolds
8.3. Drug Delivery Systems.
8.4. Healing Products
8.5. Surgical Implant Devices
8.6. Wound Closure
8.7. Dentistry
8.8. Therapeutic Imaging
9. Americas Biopolymers for Medical Applications Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biopolymers for Medical Applications Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Biopolymers for Medical Applications Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. BASF SE
13.2. Corbion N.V.
13.3. DuPont de Nemours Inc
13.4. Eastman Chemical Company
13.5. Evonik Industries
13.6. Geistlich Pharma AG
13.7. GELITA AG
13.8. HyMedPoly
13.9. INEOS Styrolution
13.10. ITV Denkendorf Product Service GmbH
13.11. NatureWorks
13.12. PSS Polymer Standards Service GmbH
13.13. Solvay
13.14. Toray Industries Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: DYNAMICS
FIGURE 2. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2021 VS 2027 (%)
FIGURE 22. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2021 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2027
FIGURE 24. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 29. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2027
FIGURE 31. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY STATE, 2019-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2019-2027 (USD MILLION)
TABLE 35. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY STATE, 2019-2027 (USD MILLION)
TABLE 37. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2019-2027 (USD MILLION)
TABLE 40. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY STATE, 2019-2027 (USD MILLION)
TABLE 42. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY STATE, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY STATE, 2019-2027 (USD MILLION)
TABLE 89. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 112. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 116. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 120. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: SCORES
TABLE 122. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: BUSINESS STRATEGY
TABLE 123. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: PRODUCT SATISFACTION
TABLE 124. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: RANKING
TABLE 125. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 126. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: MERGER & ACQUISITION
TABLE 127. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 128. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 129. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: INVESTMENT & FUNDING
TABLE 130. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 131. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • BASF SE
  • Corbion N.V.
  • DuPont de Nemours Inc
  • Eastman Chemical Company
  • Evonik Industries
  • Geistlich Pharma AG
  • GELITA AG
  • HyMedPoly
  • INEOS Styrolution
  • ITV Denkendorf Product Service GmbH
  • NatureWorks
  • PSS Polymer Standards Service GmbH
  • Solvay
  • Toray Industries Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...